肾内科指南

订阅

MedSci主页 / 所有栏目 / 肾内科指南

2019 ERBP临床实践指南：成人血液透析患者动静脉瘘和移植物围术期和术后护理

2019-06-01 欧洲肾脏最佳临床实践 Nephrol Dial Transplant. 2019 Jun 1;34(Supplement_

血液透析动静脉瘘移植物血管通路

2019年6月，欧洲肾脏最佳临床实践(ERBP)血管通路小组发布了成人血液透析患者动静脉瘘和移植物围术期和术后护理指南，指南共包括12部分内容，主要目的是为临床医生和卫生保健人员在血液透析血管通路的管理提供决策支持和指导。

中文标题：

2019 ERBP临床实践指南：成人血液透析患者动静脉瘘和移植物围术期和术后护理

英文标题：

Clinical practice guideline on peri- and postoperative care of arteriovenous fistulas and grafts for haemodialysis in adults.

发布机构：

欧洲肾脏最佳临床实践

发布日期：

2019-06-01

简要介绍：

2019年6月，欧洲肾脏最佳临床实践(ERBP)血管通路小组发布了成人血液透析患者动静脉瘘和移植物围术期和术后护理指南，指南共包括12部分内容，主要目的是为临床医生和卫生保健人员在血液透析血管通路的管理提供决策支持和指导。 

拓展指南：与透析相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2019 ERBP临床实践指南：成人血液透析患者动静脉瘘和移植物围术期和术后护理)] GetToolGuiderByIdResponse(projectId=1, id=c8a681c001e51561, title=2019 ERBP临床实践指南：成人血液透析患者动静脉瘘和移植物围术期和术后护理, enTitle=Clinical practice guideline on peri- and postoperative care of arteriovenous fistulas and grafts for haemodialysis in adults., guiderFrom=Nephrol Dial Transplant. 2019 Jun 1;34(Supplement_, authorId=null, author=, summary=2019年6月，欧洲肾脏最佳临床实践(ERBP)血管通路小组发布了成人血液透析患者动静脉瘘和移植物围术期和术后护理指南，指南共包括12部分内容，主要目的是为临床医生和卫生保健人员在血液透析血管通路的管理提供决策支持和指导。 , cover=, journalId=null, articlesId=null, associationId=918, associationName=欧洲肾脏最佳临床实践, associationIntro=The ERA-EDTA Council has nominated an advisory board to discuss and define the future of European nephrology recommendations and guidance. The 21 members of this board met for the first time in January 2008, in Paris. Due to a substantial change in philosophy (see Zoccali C. et al: European Best Practice Quo Vadis? From European Best Practice Guidelines to European Renal Best Practice), it was decided to change the name of the initiative from European Best Practice Guidelines (EBPG) to European Renal Best Practice (ERBP)., copyright=0, guiderPublishedTime=Sat Jun 01 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>2019年6月，欧洲肾脏最佳临床实践(ERBP)血管通路小组发布了成人血液透析患者动静脉瘘和移植物围术期和术后护理指南，指南共包括12部分内容，主要目的是为临床医生和卫生保健人员在血液透析血管通路的管理提供决策支持和指导。 </div> <div><br> </div>拓展指南：<strong>与<font color=red>透析</font>相关指南：</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=ac0e21c001ea6989" title="2019 AIOM/SIN共识意见：慢性肾病或血液透析的癌症患者的靶向治疗管理" target=_blank>2019 AIOM/SIN共识意见：慢性肾病或血液透析的癌症患者的靶向治疗管理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=d1afe1c001e2a452" title="2019 香港肾脏服务临床实践指南：血液透析" target=_blank>2019 香港肾脏服务临床实践指南：血液透析</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=5616a1c001e18906" title="2019 ESPN共识：需要维持性血液透析儿童患者的血管通路" target=_blank>2019 ESPN共识：需要维持性血液透析儿童患者的血管通路</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=12bef1c001e05a89" title="2019 PCRRT工作组建议：儿童透析中低血压" target=_blank>2019 PCRRT工作组建议：儿童透析中低血压</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=04afb1c00165522f" title="2018 KHA-CARI指南：血液透析中心感染控制建议" target=_blank>2018 KHA-CARI指南：血液透析中心感染控制建议</a></li> 更多信息请点击：<a href="https://www.medsci.cn/guideline/list.do?q=%E9%80%8F%E6%9E%90" target=_blank>有关透析更多指南</a></ul>, tagList=[TagDto(tagId=2080, tagName=血液透析), TagDto(tagId=37020, tagName=动静脉瘘), TagDto(tagId=3693, tagName=移植物), TagDto(tagId=4714, tagName=血管通路)], categoryList=[CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10175, appHits=368, showAppHits=0, pcHits=4945, showPcHits=6876, likes=91, shares=25, comments=7, approvalStatus=1, publishedTime=Sun Jun 23 23:55:50 CST 2019, publishedTimeString=2019-06-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Jun 23 23:55:50 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 22:42:42 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 ERBP临床实践指南：成人血液透析患者动静脉瘘和移植物围术期和术后护理)])
2019 ERBP临床实践指南：成人血液透析患者动静脉瘘和移植物围术期和术后护理
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=926304, encodeId=39aa926304a9, content=666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/dxMDTArOn5nv4BqXkia9TCrBWcnBen3ZQ7kbzfQ7Qmq7zLiclmhKl5Uw9MIibEFcwX4picMtU23kOzdMLrvnLkD3Kg/132, createdBy=64881950906, createdName=Phyer, createdTime=Mon Feb 22 10:14:29 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903551, encodeId=7ac390355126, content=想下载学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44665436522, createdName=ms1000000245666915, createdTime=Mon Nov 30 14:16:03 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891062, encodeId=22f889106246, content=很好呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epq0Rc0D2j9EsiaxKUYA7XnrV7DZAgXfxwO9nSXsQ7CzHJXAkULeAC3FQ5FDzRdD7Z73oMGic9icLq4g/132, createdBy=76b65247055, createdName=姜姜5056, createdTime=Sat Oct 10 14:10:31 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809337, encodeId=230680933e3f, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=ms1000000302953060, createdTime=Sun Aug 16 11:39:09 CST 2020, time=2020-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809249, encodeId=1cc1809249e2, content=这个好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200815/b94a606e93384b6895dec707bcf6a1ed/a735f2e62ff348ecb611529d1be896aa.jpg, createdBy=da175411049, createdName=ms4000001311587951, createdTime=Sat Aug 15 21:41:27 CST 2020, time=2020-08-15, status=1, ipAttribution=)]
    2021-02-22 Phyer

    666

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=926304, encodeId=39aa926304a9, content=666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/dxMDTArOn5nv4BqXkia9TCrBWcnBen3ZQ7kbzfQ7Qmq7zLiclmhKl5Uw9MIibEFcwX4picMtU23kOzdMLrvnLkD3Kg/132, createdBy=64881950906, createdName=Phyer, createdTime=Mon Feb 22 10:14:29 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903551, encodeId=7ac390355126, content=想下载学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44665436522, createdName=ms1000000245666915, createdTime=Mon Nov 30 14:16:03 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891062, encodeId=22f889106246, content=很好呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epq0Rc0D2j9EsiaxKUYA7XnrV7DZAgXfxwO9nSXsQ7CzHJXAkULeAC3FQ5FDzRdD7Z73oMGic9icLq4g/132, createdBy=76b65247055, createdName=姜姜5056, createdTime=Sat Oct 10 14:10:31 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809337, encodeId=230680933e3f, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=ms1000000302953060, createdTime=Sun Aug 16 11:39:09 CST 2020, time=2020-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809249, encodeId=1cc1809249e2, content=这个好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200815/b94a606e93384b6895dec707bcf6a1ed/a735f2e62ff348ecb611529d1be896aa.jpg, createdBy=da175411049, createdName=ms4000001311587951, createdTime=Sat Aug 15 21:41:27 CST 2020, time=2020-08-15, status=1, ipAttribution=)]
    2020-11-30 ms1000000245666915

    想下载学习学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=926304, encodeId=39aa926304a9, content=666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/dxMDTArOn5nv4BqXkia9TCrBWcnBen3ZQ7kbzfQ7Qmq7zLiclmhKl5Uw9MIibEFcwX4picMtU23kOzdMLrvnLkD3Kg/132, createdBy=64881950906, createdName=Phyer, createdTime=Mon Feb 22 10:14:29 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903551, encodeId=7ac390355126, content=想下载学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44665436522, createdName=ms1000000245666915, createdTime=Mon Nov 30 14:16:03 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891062, encodeId=22f889106246, content=很好呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epq0Rc0D2j9EsiaxKUYA7XnrV7DZAgXfxwO9nSXsQ7CzHJXAkULeAC3FQ5FDzRdD7Z73oMGic9icLq4g/132, createdBy=76b65247055, createdName=姜姜5056, createdTime=Sat Oct 10 14:10:31 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809337, encodeId=230680933e3f, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=ms1000000302953060, createdTime=Sun Aug 16 11:39:09 CST 2020, time=2020-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809249, encodeId=1cc1809249e2, content=这个好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200815/b94a606e93384b6895dec707bcf6a1ed/a735f2e62ff348ecb611529d1be896aa.jpg, createdBy=da175411049, createdName=ms4000001311587951, createdTime=Sat Aug 15 21:41:27 CST 2020, time=2020-08-15, status=1, ipAttribution=)]
    2020-10-10 姜姜5056

    很好呀

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=926304, encodeId=39aa926304a9, content=666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/dxMDTArOn5nv4BqXkia9TCrBWcnBen3ZQ7kbzfQ7Qmq7zLiclmhKl5Uw9MIibEFcwX4picMtU23kOzdMLrvnLkD3Kg/132, createdBy=64881950906, createdName=Phyer, createdTime=Mon Feb 22 10:14:29 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903551, encodeId=7ac390355126, content=想下载学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44665436522, createdName=ms1000000245666915, createdTime=Mon Nov 30 14:16:03 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891062, encodeId=22f889106246, content=很好呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epq0Rc0D2j9EsiaxKUYA7XnrV7DZAgXfxwO9nSXsQ7CzHJXAkULeAC3FQ5FDzRdD7Z73oMGic9icLq4g/132, createdBy=76b65247055, createdName=姜姜5056, createdTime=Sat Oct 10 14:10:31 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809337, encodeId=230680933e3f, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=ms1000000302953060, createdTime=Sun Aug 16 11:39:09 CST 2020, time=2020-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809249, encodeId=1cc1809249e2, content=这个好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200815/b94a606e93384b6895dec707bcf6a1ed/a735f2e62ff348ecb611529d1be896aa.jpg, createdBy=da175411049, createdName=ms4000001311587951, createdTime=Sat Aug 15 21:41:27 CST 2020, time=2020-08-15, status=1, ipAttribution=)]
    2020-08-16 ms1000000302953060

    好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=926304, encodeId=39aa926304a9, content=666, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/dxMDTArOn5nv4BqXkia9TCrBWcnBen3ZQ7kbzfQ7Qmq7zLiclmhKl5Uw9MIibEFcwX4picMtU23kOzdMLrvnLkD3Kg/132, createdBy=64881950906, createdName=Phyer, createdTime=Mon Feb 22 10:14:29 CST 2021, time=2021-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903551, encodeId=7ac390355126, content=想下载学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44665436522, createdName=ms1000000245666915, createdTime=Mon Nov 30 14:16:03 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891062, encodeId=22f889106246, content=很好呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epq0Rc0D2j9EsiaxKUYA7XnrV7DZAgXfxwO9nSXsQ7CzHJXAkULeAC3FQ5FDzRdD7Z73oMGic9icLq4g/132, createdBy=76b65247055, createdName=姜姜5056, createdTime=Sat Oct 10 14:10:31 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809337, encodeId=230680933e3f, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=ms1000000302953060, createdTime=Sun Aug 16 11:39:09 CST 2020, time=2020-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809249, encodeId=1cc1809249e2, content=这个好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200815/b94a606e93384b6895dec707bcf6a1ed/a735f2e62ff348ecb611529d1be896aa.jpg, createdBy=da175411049, createdName=ms4000001311587951, createdTime=Sat Aug 15 21:41:27 CST 2020, time=2020-08-15, status=1, ipAttribution=)]
    2020-08-15 ms4000001311587951

    这个好

    0

相关指南

2019 AIOM/SIN共识意见：慢性肾病或血液透析的癌症患者的靶向治疗管理

意大利肿瘤医学协会(AIOM,Italian Association of Medical Oncology) · 2019-05-31

2019 香港肾脏服务临床实践指南：血液透析

香港医学相关专家组（统称） · 2019-03-02

2019 ESPN共识：需要维持性血液透析儿童患者的血管通路

欧洲儿科肾脏病学会(ESPU,European Society for Paediatric Nephrology) · 2019-03-11

2018 KHA-CARI指南：血液透析中心感染控制建议

澳大利亚肾病指南委员会(CARI,Caring for Australasians with Renal Impairment) · 2018-10-16

2017年ISRNM《血液透析治疗期间饮食》专家共识解读

暂未更新 · 2018-07-20

2017 ISRNM共识声明：血液透析治疗期间饮食

国际肾营养和代谢学会(ISRNM,International Society of Renal Nutrition and Metabolism) · 2017-12-20